HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
Travere Therapeutics, Inc. (NASDAQ:TVTX) is among the 10 Best Growth Stocks Under $100 to Buy Now.
Travere Therapeutics Inc. (TVTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 13,000,000 | $12,780,300 | 7.67% | ||
| 2. | 11,615,000 | $11,462,554 | -8% | 0.35% | |
| 3. | 1,377,000 | $1,351,652 | +34% | 0.03% | |
| 4. | 30,000 | $29,679 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.85 | 5,000 | Officer, Director | 245,556 | 2017-06-14 | Filing | |
| $15.31 | 5,000 | Director | 52,000 | 2016-03-04 | Filing | |
| $8.60 | 15,000 | Director | 35,000 | 2014-11-25 | Filing | |
| $8.38 | 6,100 | Director | 129,165 | 2014-11-21 | Filing | |
| $8.50 | 8,700 | Officer, Director | 371,756 | 2014-11-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.05 | 1,784 | 93,126 | 2025-05-05 | Filing | ||
| $21.05 | 18,924 | 419,173 | 2025-05-05 | Filing | ||
| $21.05 | 1,771 | 128,215 | 2025-05-05 | Filing | ||
| $21.05 | 3,198 | 100,241 | 2025-05-05 | Filing | ||
| $21.05 | 4,920 | 89,482 | 2025-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | Css LlcBOND | 21,110,000 | $20,826,366 | 1.14% |
| 2. | 8,000 | $7,852,736 | 0.3% | |
| 3. | 1,040,000 | $1,030,294 | 0% | |
| 4. | 9,460,000 | $9,285 | 0.01% | |
| 5. | 0 | $0 | 0% |
News See All
10 Best Growth Stocks Under $100 to Buy Now
Even if asked by a layman where they would want to invest, the answer would be straight: growth stocks.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Travere Therapeutics First Quarter and Full Year 2025 Financial Results Conference Call. Today's call is being recorded.
10 Best Small-Cap Stocks to Buy Before They Explode
Since the announcement of tariffs, investors have been concerned regarding the market volatility.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. Today's call is being recorded.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2024 Earnings Call Transcript
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2024 Earnings Call Transcript October 31, 2024Travere Therapeutics, Inc. misses on earnings expectations.
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Travere Therapeutics' Second Quarter 2024 Financial Results and Corporate Update Conference Call. Today's call is being recorded.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript
Travere Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.7639 EPS, expectations were $-0.98. Travere Therapeutics, Inc.
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
Billionaire Hedge Funds
